acute on chronic liver failure aclf epidemiology forecast

• ACLF is more prevalent in Asian countries such as Japan due to the high burden of chronic liver diseases, aging populations, viral hepatitis infections, alcohol-related liver injury, and increasing prevalence of metabolic disorders that contribute to liver decompensation and organ failure. 
• Females face a higher lifetime risk of developing ACLF and experience a greater disease burden compared to males. This disparity is largely attributed to differences in disease progression, hormonal and metabolic factors, higher susceptibility to immune dysregulation, and the increasing prevalence of underlying chronic liver disorders and associated comorbidities. 
• The prevalence of ACLF, defined by the Japanese criteria that consider single hepatic failure, was nearly 36.5%. This highlights the impact of different diagnostic criteria on the reported prevalence of ACLF, particularly when hepatic failure is included as a key factor
• The rising prevalence of chronic liver diseases, alcohol-related liver injury, viral hepatitis, metabolic disorders, and increasing rates of infections and organ dysfunction are expected to sustain the global ACLF burden over the next decade. Strengthening early diagnosis, improving management of underlying liver diseases, expanding access to liver transplantation, and developing effective targeted therapies will remain key determinants of future trends.

Acute on Chronic Liver Failure (ACLF) Epidemiology Forecast

• 2025 Prevalent Cases of ACLF: ~XXXX million
• ACLF Growth Rate (2026–2036): ~XX% CAGR

DelveInsight's ‘Acute on Chronic Liver Failure (ACLF)– Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the ACLF, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Acute on Chronic Liver Failure (ACLF) Understanding and Diagnosis Algorithm

ACLF Overview

ACLF is a rapidly progressing complication of chronic liver disease or cirrhosis marked by acute hepatic decompensation and multi-organ failure, leading to high short-term mortality. Common manifestations include jaundice, ascites, hepatic encephalopathy, gastrointestinal bleeding, and infections, often triggered by bacterial infections, alcohol-related injury, viral hepatitis reactivation, or drug-induced liver damage. 

ACLF Diagnosis

ACLF is diagnosed through clinical evaluation, laboratory investigations, and assessment of organ failure in patients with chronic liver disease or cirrhosis. Diagnostic workup includes liver and kidney function tests, coagulation profile, CBC, viral markers, blood cultures, and imaging studies to identify triggers and complications, while severity and prognosis are commonly evaluated using MELD and CLIF-C ACLF scoring systems.

Note: Further details are provided in the report.

Acute on Chronic Liver Failure (ACLF) Epidemiology

Key Findings from ACLF Epidemiological Analysis and Forecast 

• ACLF is highly prevalent among hospitalized patients with decompensated cirrhosis, with significant regional variations in disease burden and severity across Europe, Asia, and America.
• The observed female predominance and earlier onset of ACLF highlight the importance of early disease monitoring, timely diagnosis, and improved access to preventive and supportive care strategies to reduce disease progression and mortality. 

Scope of the Acute on Chronic Liver Failure Market Report

• The Acute on Chronic Liver Failure Market report covers a segment of an executive summary, a descriptive overview of ACLF, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Acute on Chronic Liver Failure Market Report Insights

Acute on Chronic Liver Failure (ACLF) Patient Population Forecast

Acute on Chronic Liver Failure Market Report Key Strengths

• Epidemiology‑based (epi‑based) Bottom‑up Forecasting
• 11-year Forecast 
• Patient Burden Trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of ACLF? What will be the growth opportunities across the 7MM concerning the patient population with ACLF?
• What is the historical and forecasted ACLFpatient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy the Acute on Chronic Liver Failure Market Report

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.